| Revista: | Brazilian Journal of Pharmaceutical Sciences |
| Base de datos: | PERIÓDICA |
| Número de sistema: | 000451941 |
| ISSN: | 1984-8250 |
| Autors: | Joshi, Manjusha1 Gokhale, Chinmay1 Kenjale, Prathmesh1 Pokharkar, Varsha1 |
| Institucions: | 1Bharati Vidyapeeth University, Poona College of Pharmacy, Pune, Maharashtra. India |
| Any: | 2022 |
| Volum: | 58 |
| País: | Brasil |
| Idioma: | Inglés |
| Tipo de documento: | Artículo |
| Enfoque: | Experimental, aplicado |
| Resumen en inglés | Diltiazem hydrochloride (DLH) is a calcium channel blocker useful for the treatment of angina pectoris, arrhythmia, and hypertension. DLH having a short half-life needs frequent administration for successful treatment but this poses a problem of poor patient compliance. These requirements are served by elementary osmotic pump tablets (EOP) based controlled-release (CR) systems. Quality by design (QbD) approach assists in screening various factors with subsequent assessment of critical parameters that can have a major impact on the scalability of EOP. Tablets were formulated using wet granulation method followed by osmotic coating. Factorial design based QbD strategy aided in defining the risk assessment of influential variables such as hydrophilic polymers and osmotic coat component on the in-vitro release kinetics of the designed EOP tablets. These formulated EOP systems followed zero-order kinetics, a characteristic feature of EOPs. EOP tablets were formulated applying a systematic QbD statistical approach. The formulated DLH EOP systems with improved concentration-independent behavior helped to address the challenges of IR formulation. Application of QbD strategy in ascertaining the scalability of DLH EOP formulation would help pharmaceutical industries in the translation of EOP based drug delivery systems from R&D to market |
| Disciplines | Química |
| Paraules clau: | Química farmacéutica, Tabletas, Clorhidrato de Diltiazem, Diseño de fármacos, Bomba osmótica, Diseño factorial |
| Keyword: | Medicinal chemistry, Tablets, Diltiazem hydrochloride, Osmotic pump, Drug design, Factorial design |
| Text complet: | Texto completo (Ver HTML) Texto completo (Ver PDF) |
